Nicholas M Moore
Overview
Explore the profile of Nicholas M Moore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sundermann A, Rosa R, Harris P, Snitkin E, Javaid W, Moore N, et al.
Antimicrob Agents Chemother
. 2024 Dec;
69(1):e0147924.
PMID: 39636107
Pathogen genomic surveillance in healthcare has the potential to enhance patient safety by detecting outbreaks earlier, thereby reducing morbidity and mortality. Despite benefits, there are barriers to adoption, including cost,...
2.
Narayanan N, Mathers A, Wenzler E, Moore N, Giske C, Mendes R, et al.
Clin Infect Dis
. 2024 May;
80(2):481-482.
PMID: 38709848
No abstract available.
3.
Narayanan N, Mathers A, Wenzler E, Moore N, Giske C, Mendes R, et al.
Clin Infect Dis
. 2024 Apr;
79(2):516-523.
PMID: 38626241
Amoxicillin-clavulanate (AMC) is among the most frequently prescribed antibiotics globally. It has broad antibacterial activity against gram-positive, gram-negative, and anaerobic bacteria and has been used to treat infections caused by...
4.
Sansom S, Shimasaki T, Dangana T, Lin M, Schoeny M, Fukuda C, et al.
J Infect Dis
. 2024 Mar;
230(4):807-815.
PMID: 38546721
Background: Admission and discharge screening of patients for asymptomatic gut colonization with multidrug-resistant organisms (MDROs) is a common approach to active surveillance, but its sensitivity for detecting colonization is uncertain....
5.
Anderson M, Hodges A, Luk K, Olivo A, Forberg K, Meyer T, et al.
J Infect Dis
. 2023 Sep;
229(Supplement_2):S137-S143.
PMID: 37739785
Background: The 2022 outbreak of the clade IIb monkeypox virus and subsequent global spread lead to an urgent need for the development of high-throughput, sensitive, and reproducible diagnostic tests. Methods:...
6.
Sullivan E, Macias Jimenez M, Moore N
Lab Med
. 2023 Sep;
54(6):e204-e206.
PMID: 37658816
Background: Rapid detection of carbapenemase production in gram negative bacilli has important treatment considerations. Objective: We evaluated a lateral flow assay (LFA) for carbapenemase production compared with molecular detection of...
7.
Prinzi A, Moore N
Open Forum Infect Dis
. 2023 Jul;
10(7):ofad269.
PMID: 37408854
The process of bacterial nomenclature change has evolved in complexity over time and continues to be an iterative process that is not without challenges. The importance and feasibility of such...
8.
Sansom S, Barbian H, Hayden M, Fukuda C, Moore N, Thotapalli L, et al.
Open Forum Infect Dis
. 2022 Dec;
9(11):ofac581.
PMID: 36467294
Background: Identifying the source of healthcare personnel (HCP) coronavirus disease 2019 (COVID-19) is important to guide occupational safety efforts. We used a combined whole genome sequencing (WGS) and epidemiologic approach...
9.
Whitney E, Pitrak D, Beavis K, Moore N, Shankaran S, Abeleda A, et al.
J Clin Microbiol
. 2022 Nov;
60(12):e0120422.
PMID: 36448814
Identification of individuals with acute HIV infection (AHI) and rapid initiation of antiretroviral therapy (ART) are priorities for HIV elimination efforts. Fourth- and fifth-generation HIV-1/HIV-2 antigen (Ag)/antibody (Ab) combination assays...
10.
Sansom S, Logan L, Green S, Moore N, Hayden M
Antimicrob Steward Healthc Epidemiol
. 2022 Sep;
1(1):e18.
PMID: 36169403
No abstract available.